OnKure Therapeutics, Inc.
OKUR
$4.25
-$0.15-3.41%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.91M | 3.41M | 3.59M | 3.71M | 3.99M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.62M | 14.13M | 15.50M | 16.32M | 17.00M |
| Operating Income | -15.62M | -14.13M | -15.50M | -16.32M | -17.00M |
| Income Before Tax | -15.16M | -13.50M | -14.70M | -15.39M | -15.93M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -15.16M | -13.50M | -14.70M | -15.39M | -15.93M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.16M | -13.50M | -14.70M | -15.39M | -15.93M |
| EBIT | -15.62M | -14.13M | -15.50M | -16.32M | -17.00M |
| EBITDA | -15.51M | -14.02M | -15.39M | -16.21M | -16.88M |
| EPS Basic | -1.11 | -0.99 | -1.09 | -1.14 | -1.19 |
| Normalized Basic EPS | -0.69 | -0.62 | -0.68 | -0.71 | -0.74 |
| EPS Diluted | -1.11 | -0.99 | -1.09 | -1.14 | -1.19 |
| Normalized Diluted EPS | -0.69 | -0.62 | -0.68 | -0.71 | -0.74 |
| Average Basic Shares Outstanding | 13.67M | 13.60M | 13.53M | 13.51M | 13.42M |
| Average Diluted Shares Outstanding | 13.67M | 13.60M | 13.53M | 13.51M | 13.42M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |